Effectiveness of fenalgin SPOFA in lumboischiadic syndrome
Drobný, M.; Wolfová, E.; Adamkov, J.; Bevilaqua, L.; Fundárek, J.; Pithová, B.; Knéslová, L.
Bratislavske Lekarske Listy 71(4): 421-428
1979
ISSN/ISBN: 0006-9248 PMID: 156058 Document Number: 150165
Document emailed within 1 workday
Related Documents
Sulla, I.; Fagul'a, J.; Výrostko, J.; Santa, M. 1991: Problems of recurrence and reoperations in discogenic lumboischiadic syndromes. 1 Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 58(1-2): 60-68Macela, A. 1970: Clofibrate Spofa Casopis Lekaru Ceskych 109(30): 700-701
Macela, A. 1971: Anti-co Spofa suppositories Casopis Lekaru Ceskych 110(36): 853-854
Semonský, M.; Zikán, V.; Veselá, H. 1973: Cytembena Spofa--a new antineoplastic agent Ceskoslovenska Farmacie 22(7): 313-321
Oláh, Z. 1971: Use of Clofibrate SPOFA in the treatment of diabetic retinopathy Ceskoslovenska Oftalmologie 27(5): 315-318
Novotný, P. 1972: Pyrvinium Spofa. new drug for the treatment of enterobiasis Casopis Lekaru Ceskych 111(36): 841-842
Klener, P.; Donner, L. 1975: Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas Neoplasma 22(1): 55-62
Cernohorský, D.; Král, B.; Hamet, A.; Eliás, J.; Tilser, P.; Rozánek, P.; Sramar, V.; Koudelka, V. 1986: Effect of dihydralazine Spofa on precapillary pulmonary hypertension Vnitrni Lekarstvi 32(9): 855-861
Masáreová, E.; Inczinger, F.; Bózner, A. 1971: Influencing of the isoprenaline necrosis of the myocardium by ATP-Spofa administration Ceskoslovenska Patologie 7(2): 109-112
Grafnetterová, J.; König, J.; Krepelka, J.; Cerný, A.; Klíma, J.; Krebs, V.; Charvát, J. 1985: Problems with the Czechoslovak cytostatic agent Benin Spofa Casopis Lekaru Ceskych 124(26): 820-823
Janda, J.; Marek, V.; Reitspiesová, K.; Sikut, M.; Korous, J. 1982: Standardized concentration test in school children using Adiuretin Spofa Ceskoslovenska Pediatrie 37(5): 285-288
Havlik, J.; Holý, M. 1976: Erythromycin stearate Spofa--coated tablets for pediatric practice Ceskoslovenska Pediatrie 31(7): 402-404
Navrátil, J.; Hrbek, J.; Dvorák, M. 1972: The therapeutic effect of Stenolon Spofa on female neurotic patients Activitas Nervosa Superior 14(2): 102-103
Dvorák, K.; Presl, J. 1986: Biological testing of methenmadinone acetate (Superlutin Spofa) in clinical trials Ceskoslovenska Gynekologie 51(9): 714-719
Petrásek, J.; Cakrtová, M.; Dejmal, V. 1973: Rheologic situation in the vascular bed after infusion of a macromolecular solution (Rheodextran Spofa) Casopis Lekaru Ceskych 112(1): 23-25
Kovãcsová, B.; Inczinger, F.; Edelsteinovă, S.; Doupovcovă, M. 1972: Effect of K and Mg asparaginate infusions (cardilan Spofa) on LDH isoenzymes in the experimentally injured myocardium Ceskoslovenska Farmacie 21(8): 348-352
Svacinka, P.; Horký, J.; Blahníková, L. 1970: Our experience with long-term therapy of chronic liver diseases using Superanabolon Spofa Vnitrni Lekarstvi 16(12): 1181-1187
Kudlác, E.; Píchová, D. 1990: The adenohypophyseal response and effect of GnRh (Dirigestran inj. Spofa) administration in cows in the postpartum period Veterinarni Medicina 35(6): 321-330
Navrátil, S.; Knotek, Z.; Manásková, M.; Martínek, J.; Stefan, M.; Soukup, T.; Soukupová, I. 1992: Verification of the usefulness of Estrophan inj. Spofa in the control of reproductive parameters in sows after weaning of piglets Veterinarni Medicina 37(9-10): 509-516
Krajnicáková, M.; Elecko, J.; Bekeová, E.; Maracek, I.; Hendrichovský, V. 1991: Biometric parameters of the uterus and ovaries in sheep after administration of Depotocin inj. Spofa in early puerperium Veterinarni Medicina 36(10): 607-618